Breakthrough in Haemophilia treatment – Video

11-12-2011 13:07 Doctors are hailing a major breakthrough in gene therapy that could revolutionise treatment of the blood clotting disorder Haemophilia. Sufferers currently have to take an ongoing series of injections to control the condition. A study at University College London hopes to change all that. Al Jazeera's Gerald Tan has been taking a look at the findings.

Go here to see the original:

Breakthrough in Haemophilia treatment - Video

Research and Markets: Recent Advances in Cancer Research and Therapy – Increased Research on one of the Major Causes …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/msjp88/recent_advances_in) has announced the addition of Elsevier Science and Technology's new report "Recent Advances in Cancer Research and Therapy" to their offering.

Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super Interferon, HecI based and liposome based therapy, gene therapy, and p53 based cancer therapy. There is also a discussion of current cancer research in China including traditional Chinese medicine. Written by leading scientists in the field, this book provides an essential insight into the current state of cancer therapy and treatment.

Key Topics Covered:

1. Biotherapy of Cancer: Progress in China

2. Cancer Targeting Gene-Viro-Therapy (CTGVT) and Its Promising Future

3. Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16-F10 Melanoma Cells

4. Mitotic Regulator Hec1 as a Potential Target for Developing Breast Cancer Therapeutics

5. Advances in Liposome-based Targeted Gene Therapy of Cancer

6. Re-wiring the Intracellular Signaling Network in Cancer

See the original post:

Research and Markets: Recent Advances in Cancer Research and Therapy - Increased Research on one of the Major Causes ...

What is Gene Therapy?

what-is-gene-therapy

Gene Therapy is the transfer of genetic material (gene transfer) to dysfunctional cells to correct a deficiency in the DNA or genome of a patient. Cell Therapy, such as stem cell therapy, can also be used to achieve these goals. Gene therapy can be applied to genetic disorders as well as diseases acquired over the lifetime of an individual, such as cancer or infection, to confer a specific property to the cell allowing it to combat the disease.

For more information browse our education section.

Corporate Membership

The Gene Therapy Review announces the establishment of a yearly corporate membership option for companies wishing to promote their services throughout our website. This is a new service designed to incorporate all the benefits of advertising on the Gene Therapy Review into a single, easy-to-manage package.

Benefits include:

1. Establishment and maintenance of a page devoted to your company, its products and services in the relevant section of our website (linked to from our homepage for a fixed period of time; at least 3 months)

2. Unlimited advertising on the site in sections chosen by you, e.g. banner or box ads

3. Unlimited posting of job vacancies in your company

4. Full page advert in the yearly print issue distributed by EBSCO and available for purchase through Amazon

5. Unlimited press releases published on the site, again linked to from the homepage for a fixed period of time (at least 3 months)

6. Unlimited articles describing the application of your technology

7. Yearly support to enable updates to your company page

8. Advanced ad tracking system to monitor who is clicking your ads and viewing your page

For a limited time period we are now charging an introductory price of $299 for annual subscription to this service; with revenue obtained from this nominal corporate membership fee helping keep the Gene Therapy Review an open resource for the broader scientific community.

If you are interested in listing your company on the Gene Therapy Review please contact the Editor-in-Chief, Dr Michael Roberts at mlroberts@genetherapyreview.com

Gene Therapy Job Board

Gene Therapy Job BoardThe gene therapy review has established a job bulletin board where academic groups are welcome to advertise positions free of charge. We also give excellent advertisement rates for companies wishing to publish their open positions. To advertise on the gene therapy review job bulletin board, please contact info@genetherapyreview.com.

Editorial Board

Gene Therapy Review Editorial BoardThe Gene Therapy Review is assembling an editorial board in order to facilitate the exapnsion of this open resource, enabling peer review and ultimate listing on resources such as PubMed. If you are interested in participating in this growing project then please contact the associate editor; mvougiouka@genetherapyreview.com

Currently the board consists of:

Editor-in-Chief: Michael L Roberts, PhD

Dr Roberts has more than 15 year experience in the Gene Therapy Sector, graduating from Glasgow University with first class honours and receiving his PhD from Cambridge University (Magdalene). He has post-doctoral research experience at Royal Holloway and the National Hellenic Research Foundation as a Marie Curie Fellow. After serving on the board of Regulon and directing R&D, he founded Synpromics, where he is President and CEO.

Associate Editor: Maria Vougiouka, BSc

Ms Vougiouka has more than 10 years experience in the scientific publishing sector. She played a key role in setting up Gene Therapy Press, where she administered two peer-reviewed journal; Gene Therapy and Molecular Biology (GTMB) and Cancer Therapy. She also has accrued several years experience in the regulatory industry where she worked for Wyeth and Pfizer.

Editorial Board Members

Jani K Raty, PhD - Head of Information Management, Amsterdam Molecular Therapeutics, The Netherlands.

Pankaj Kumar, PhD - Post-Doctoral Research Associate, Binghampton University, NY, USA.

Ekaterina Semenova, PhD - Post-Doctoral Research Associate, UCL Institute of Child Health, London, UK.

Welcome to the Gene Therapy Review

DNA Double HelixWe welcome you to the Gene Therapy Review and would like to encourage you to contribute to our online resource.

The site was founded in 2008 with a view to establishing the most comprehensive gene therapy resource on the web, with content provided by the gene therapy community. If you chose to contribute articles or blog entries to the Gene Therapy Review we will upgrate your account to AUTHOR status after registration, entitling you to edit your own content. Articles will also be published in our print edition, which is published four times a year and is edited by Dr Michael L. Roberts who has more than 15 years experience developing various gene transfer vector systems

If you contribute more than ten articles or blog entries then you may apply for EDITOR status, allowing you to help maintain a section of the Gene Therapy Review. Successful applications depend on the quality of the articles submitted and your experience in the section of interest. For more information on sections please contact us.

Finally, we would like to encourage all users to promote the Gene Therapy Review and their contributions by adding the following line to their email signatures:

Member of the Gene Therapy Review: A free genetics educational resource - http://www.genetherapyreview.com

As users progress through the levels of membership they may update this signature to reflect their status. We hope that this will help raise awareness of the Gene Therapy Review and hence promote your own contributions and the profile of our resource as a whole.

Please also ensure that your profile details are up-to-date. You can access and edit your profile page after you register and log in using the links in the User Menu on the left-hand side of each page.

At present the Gene Therapy Review comprises the following features:

Gene Therapy News: All the breaking news in the gene therapy arena can be found in our news pages. You can read how the latest research will likely impact on the field in analysis. For those seeking employment in the sector, we have established a job bulletin board, where academics are invited to advertise for free.

Gene Therapy Research: We provide links to the home pages of all the academic research groups devoted to human genetics, gene therapy and stem cell research. In the companies section we detail the status of private sector DNA research. You can also follow their progress in our literature section where all the latest genetic engineering articles are listed

Gene Therapy Companies: We review the companies that are developing new gene transfer technologies and list the service providers that offer contract manufacturing or contract research to the field. Information on genetic disorders, cancer and infectious disease (current targets of gene therapy research) is also provided, with links to further reading on each topic.

Gene Transfer Vectors: Our gene vector pages to learn more about gene transfer into human cells. We describe all the current techniques used for gene delivery. Our technical pages also serve as a source for all commerical gene transfer vectors. These pages have links to plasmid maps, DNA sequences and manuals.

Gene Therapy Clinical Trials: Our clinical trial section contains a database containing all the published results from current and past clinical trials. For those considering enrolling in a clinical trial, a list of patient resources is also provided where we focus on genetic disorders, cancer and infectious disease. The regulatory pages provide links to the interational bodies that control clinical trial research.

Gene Therapy Literature: Our literature section contains analysis of the latest articles published in the leading gene therapy journals. You can also search pubmed from this section. Activities of the various gene therapy societies are listed and we provide a calender of all the annual international scientific congresses focussing on human genetics.

We hope you find our site useful and encourage you to leave comments as to how we can improve.

Warmest Regards,

The Editorial Team